AI assistant
Sending…
LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2017
Sep 18, 2017
32814_dirs_2017-09-18_b3d98669-8cc9-46cf-82ac-b08bb7f275a2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2017-09-15
Reporting Person: COATS LONNEL (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-15 | Common Stock | P | 300 | $12.4866 | Acquired | 3285 | Direct |
| 2017-09-15 | Common Stock | P | 300 | $12.485 | Acquired | 3585 | Direct |
| 2017-09-15 | Common Stock | P | 3300 | $12.52 | Acquired | 6885 | Direct |
| 2017-09-15 | Common Stock | P | 5200 | $12.54 | Acquired | 12085 | Direct |
| 2017-09-15 | Common Stock | P | 3247 | $12.5366 | Acquired | 15332 | Direct |
| 2017-09-15 | Common Stock | P | 4253 | $12.53 | Acquired | 19585 | Direct |
| 2017-09-15 | Common Stock | P | 400 | $12.535 | Acquired | 19985 | Direct |
| 2017-09-15 | Common Stock | P | 2400 | $12.55 | Acquired | 22385 | Direct |
| 2017-09-15 | Common Stock | P | 1951 | $12.56 | Acquired | 24336 | Direct |
| 2017-09-15 | Common Stock | P | 2000 | $12.57 | Acquired | 26336 | Direct |
| 2017-09-15 | Common Stock | P | 600 | $12.5166 | Acquired | 26936 | Direct |
| 2017-09-15 | Common Stock | P | 300 | $12.5498 | Acquired | 27236 | Direct |
| 2017-09-15 | Common Stock | P | 1200 | $12.5766 | Acquired | 28436 | Direct |
| 2017-09-15 | Common Stock | P | 149 | $12.5662 | Acquired | 28585 | Direct |
| 2017-09-15 | Common Stock | P | 194 | $12.51 | Acquired | 28779 | Direct |
| 2017-09-15 | Common Stock | P | 400 | $12.5162 | Acquired | 29179 | Direct |
| 2017-09-15 | Common Stock | P | 100 | $12.515 | Acquired | 29279 | Direct |
| 2017-09-15 | Common Stock | P | 1200 | $12.519 | Acquired | 30479 | Direct |
| 2017-09-15 | Common Stock | P | 306 | $12.537 | Acquired | 30785 | Direct |
| 2017-09-15 | Common Stock | P | 300 | $12.5761 | Acquired | 31085 | Direct |
| 2017-09-15 | Common Stock | P | 300 | $12.6466 | Acquired | 31385 | Direct |
| 2017-09-15 | Common Stock | P | 600 | $12.6166 | Acquired | 31985 | Direct |
| 2017-09-15 | Common Stock | P | 300 | $12.6161 | Acquired | 32285 | Direct |
| 2017-09-15 | Common Stock | P | 300 | $12.6232 | Acquired | 32585 | Direct |
| 2017-09-15 | Common Stock | P | 400 | $12.6361 | Acquired | 32985 | Direct |
Footnotes
F1: Since the date of Mr. Coats' last ownership report, he transferred 17,782 shares of common stock to his ex-wife pursuant to a domestic relations order. Mr. Coats no longer reports as beneficially owned any securities owned by his ex-wife.
More from LEXICON PHARMACEUTICALS, INC.
Report Publication Announcement
2026
May 7
Capital/Financing Update
2026
May 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3